Age-Related Male Hypogonadism and Cognitive Impairment in the Elderly: Focus on the Effects of Testosterone Replacement Therapy on Cognition

Abstract

Background. Epidemiological data report that male hypogonadism may play a role in cognitive impairment in elderly. However, the effect of testosterone replacement therapy (TRT) on cognitive abilities in this cluster of patients has not been well established. Methods. PubMed/MEDLINE, Google Scholar, Cochrane Library, and Web of Science were searched by using free text words and medical subject headings terms related with “male hypogonadism”, “late-onset hypogonadism”, elderly, cognition, “mild cognitive impairment”, memory, “testosterone replacement therapy” used in various combinations according to the specific clinical questions. Original articles, reviews, and randomized controlled trials written in English were selected. Results. A long-term TRT could improve specific cognitive functions, such as verbal and spatial memory, cognitive flexibility, and physical vitality. However, randomized controlled trials do not provide positive results, and in most of the cases TRT might not induce beneficial effects on cognitive function in elderly men. Discussion and conclusions. Since the lengthening of life expectancy, the prevalence rate of cognitive decline in elderly men is expected to increase remarkably over the next decade with considerable healthcare and economical concerns. Therefore, this remains a relevant clinical topic and further investigations are needed for clarifying the role of TRT especially in elderly men with hypogonadism.

Effect of Chronic Heart Failure Complicated with Type 2 Diabetes Mellitus on Cognitive Function in the Elderly

“…Some clinical data also show that there is serious cognitive impairment in senile CHF itself, and diabetes is the main factor in the development of CHF, and type 2 diabetes mellitus (T2DM) is especially common in CHF patients with CI [11][12][13]. e mortality caused by the combination of the two is higher than that in nondiabetic patients, which further aggravates the cognitive impairment, increases the hospitalization rate and mortality, and the quality of life of patients is seriously affected [14,15]. However, some studies have found that type 2 diabetes is the main factor leading to dementia and cognitive impairment in patients with CHF, and type 2 diabetes is likely to be an independent risk factor for CI [16].…”

Associations between sarcopenia and circulating branched-chain amino acids: a cross-sectional study over 100,000 participants

“…Our results are consistent with those of a recent meta-analysis [ 11 ]. We speculated that the main reasons for this are as follows: First, aging is associated with a decline in anabolic hormone levels, such as testosterone [ 45 ], and growth hormone [ 46 ], which play crucial roles in muscle protein synthesis and maintenance. Consequently, older adults may excessively rely on alternative pathways for muscle protein synthesis, with BCAAs as important substrates.…”

The dichotomy between health and drug abuse in bodybuilding

“…In clinical settings, testosterone replacement therapy (TRT) can be a tool that aids in health restoration since low endogenous levels (<300 ng/dL) of this hormone might result in health complications (Jia et al, 2015; Shin & Park, 2019). Although, for replacement therapy to be administered, an individual must be diagnosed with hypogonadism, which appears primarily associated with age (Kaufman & Vermeulen, 2005; Lisco et al, 2020; Wu et al, 2008). The benefits of TRT, when natural production is low, will improve a myriad of health markers, such as bone density, sexual function, depression and muscle mass, and it may also help prevent cardiovascular disease and metabolic syndrome (Bassil et al, 2009; Bhasin, 2021).…”